Status: Recruiting
False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study
To determine the safety and feasibility of the investigational product to reduce aortic dissection false lumen perfusion.
Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Shape Memory Medical, Inc.Updated: Mar 23, 2026Locations: 2
Eligibility criteria
≥18 years of age. [+2]
An inability to provide informed consent. [+23]